医学
经皮冠状动脉介入治疗
传统PCI
急性冠脉综合征
临床终点
心肌梗塞
内科学
比例危险模型
队列
狼牙棒
心脏病学
临床试验
作者
Yajie Cai,Qiaoning Yang,Ruixi Xi,Furong Yang,Feng Gu,Yang Zhao,Ming Guo,Guoju Dong,Z Gao,Changgeng Fu,Peili Wang,Jianpeng Du,Dawu Zhang,Wenhui Duan,Lizhi Li,Dazhuo Shi,Ruina Bai
标识
DOI:10.3389/fcvm.2024.1420194
摘要
Danlou tablets (DLTs) have been widely used to treat coronary heart disease in China. However, the benefits associated with DLT for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) in routine practice require further investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI